UNITED THERAPEUTICS Corp Quarterly Other Assets, Current in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current assets classified as other.
Summary
UNITED THERAPEUTICS Corp quarterly Other Assets, Current history and growth rate from Q2 2010 to Q3 2024.
  • UNITED THERAPEUTICS Corp Other Assets, Current for the quarter ending September 30, 2024 was $185M, a 15.9% decline year-over-year.
Other Assets, Current, Quarterly (USD)
Other Assets, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $185M -$35.1M -15.9% Sep 30, 2024 10-Q 2024-10-30
Q2 2024 $221M +$62.4M +39.4% Jun 30, 2024 10-Q 2024-07-31
Q1 2024 $113M +$20.8M +22.5% Mar 31, 2024 10-Q 2024-05-01
Q4 2023 $166M -$53M -24.2% Dec 31, 2023 10-Q 2024-10-30
Q3 2023 $221M +$102M +86.7% Sep 30, 2023 10-Q 2023-11-01
Q2 2023 $158M -$7.4M -4.46% Jun 30, 2023 10-Q 2023-08-02
Q1 2023 $92.6M +$32.4M +53.8% Mar 31, 2023 10-Q 2023-05-03
Q4 2022 $219M +$119M +118% Dec 31, 2022 10-K 2024-02-21
Q3 2022 $118M +$42.1M +55.4% Sep 30, 2022 10-Q 2022-11-02
Q2 2022 $166M +$78.7M +90.4% Jun 30, 2022 10-Q 2022-08-03
Q1 2022 $60.2M +$10.5M +21.1% Mar 31, 2022 10-Q 2022-05-04
Q4 2021 $100M +$12.1M +13.7% Dec 31, 2021 10-K 2023-02-22
Q3 2021 $76M +$28.5M +60% Sep 30, 2021 10-Q 2021-11-03
Q2 2021 $87.1M +$15.1M +21% Jun 30, 2021 10-Q 2021-08-04
Q1 2021 $49.7M -$10.5M -17.4% Mar 31, 2021 10-Q 2021-05-05
Q4 2020 $88.3M -$45.5M -34% Dec 31, 2020 10-K 2022-02-24
Q3 2020 $47.5M -$38.2M -44.6% Sep 30, 2020 10-Q 2020-10-28
Q2 2020 $72M -$3.7M -4.89% Jun 30, 2020 10-Q 2020-07-29
Q1 2020 $60.2M -$21.2M -26% Mar 31, 2020 10-Q 2020-04-29
Q4 2019 $134M +$58.4M +77.5% Dec 31, 2019 10-K 2021-02-24
Q3 2019 $85.7M +$30.8M +56.1% Sep 30, 2019 10-Q 2019-10-30
Q2 2019 $75.7M +$18.5M +32.3% Jun 30, 2019 10-Q 2019-07-31
Q1 2019 $81.4M +$17.2M +26.8% Mar 31, 2019 10-Q 2019-05-01
Q4 2018 $75.4M -$40.1M -34.7% Dec 31, 2018 10-K 2020-02-26
Q3 2018 $54.9M -$7.4M -11.9% Sep 30, 2018 10-Q 2018-10-31
Q2 2018 $57.2M -$3.3M -5.46% Jun 30, 2018 10-Q 2018-08-01
Q1 2018 $64.2M +$11.3M +21.4% Mar 31, 2018 10-Q 2018-05-02
Q4 2017 $116M +$56M +94.1% Dec 31, 2017 10-K 2019-02-27
Q3 2017 $62.3M +$25.9M +71.2% Sep 30, 2017 10-Q 2017-10-25
Q2 2017 $60.5M +$17M +39.1% Jun 30, 2017 10-Q 2017-07-27
Q1 2017 $52.9M +$10.8M +25.7% Mar 31, 2017 10-Q 2017-04-26
Q4 2016 $59.5M +$12.1M +25.5% Dec 31, 2016 10-K 2018-02-21
Q3 2016 $36.4M -$9.8M -21.2% Sep 30, 2016 10-Q 2016-10-27
Q2 2016 $43.5M -$98.9M -69.5% Jun 30, 2016 10-Q 2016-07-28
Q1 2016 $42.1M -$66.5M -61.2% Mar 31, 2016 10-Q 2016-04-28
Q4 2015 $47.4M +$14.6M +44.4% Dec 31, 2015 10-K 2017-02-22
Q3 2015 $46.2M -$61M -56.9% Sep 30, 2015 10-Q 2015-10-27
Q2 2015 $142M +$99.4M +231% Jun 30, 2015 10-Q 2015-07-28
Q1 2015 $109M +$62.3M +135% Mar 31, 2015 10-Q 2015-04-28
Q4 2014 $32.8M -$13.6M -29.3% Dec 31, 2014 10-K 2016-02-25
Q3 2014 $107M +$71.6M +201% Sep 30, 2014 10-Q 2014-10-28
Q2 2014 $43.1M +$38.1M +760% Jun 30, 2014 10-Q 2014-07-29
Q1 2014 $46.3M +$40.5M +693% Mar 31, 2014 10-Q 2014-04-29
Q4 2013 $46.4M +$11M +31.2% Dec 31, 2013 10-K 2015-02-24
Q3 2013 $35.6M -$1.75M -4.68% Sep 30, 2013 10-Q 2013-10-29
Q2 2013 $5.01M -$19.8M -79.8% Jun 30, 2013 10-Q 2013-07-25
Q1 2013 $5.84M -$16M -73.3% Mar 31, 2013 10-Q 2013-04-25
Q4 2012 $35.4M +$29.2M +472% Dec 31, 2012 10-K 2014-02-25
Q3 2012 $37.4M +$31.1M +496% Sep 30, 2012 10-Q 2012-11-01
Q2 2012 $24.8M +$13.8M +125% Jun 30, 2012 10-Q 2012-07-26
Q1 2012 $21.8M +$12.5M +133% Mar 31, 2012 10-Q 2012-04-26
Q4 2011 $6.19M -$652K -9.53% Dec 31, 2011 10-K 2013-02-26
Q3 2011 $6.28M -$2.01M -24.2% Sep 30, 2011 10-Q 2011-10-27
Q2 2011 $11M +$8.05M +270% Jun 30, 2011 10-Q 2011-07-28
Q1 2011 $9.36M Mar 31, 2011 10-Q 2011-04-28
Q4 2010 $6.84M Dec 31, 2010 10-K 2012-02-28
Q3 2010 $8.29M Sep 30, 2010 10-Q 2010-10-28
Q2 2010 $2.99M Jun 30, 2010 10-Q 2010-07-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.